Quentin qualified from Alfort Veterinary School (Paris, France) in 2014, and completed his residency in Small Animal Oncology at the University of Edinburgh in 2019. The same year, Quentin became a Diplomate in Small Animal Oncology, started an Oncology service at the Veterinary Hospital Fregis (Paris, France) and was selected to complete a one-year training in Oncology Clinical Research organised by Paris-Saclay University and the School of Cancer Sciences. Quentin moved back to the UK in 2020 to work in a referral hospital before joining Lumbry Park in 2025.
He is particularly involved in clinical research, with the hope of improving standard of care and giving his patients the best opportunities. He underwent a 1-year training in human oncology clinical research, he is a member of the ECVIM-CA Clinical Study Fund and ESVONC Clinical Research Fund, he has been awarded multiple awards for his research, and he lectures on Veterinary Immuno-oncology at the University of Surrey.
Quentin’s interests include the optimisation of chemotherapy administration, lymph node assessment, and immunotherapies. He is also passionate about developing new therapeutic and diagnostic modalities to help cancer patients, whilst embracing the One Health concept.
He is delighted to join the team and is looking forward to offer cutting-edge management to all pets diagnosed with cancer. He is very happy to discuss the details of any patient with your family veterinary surgeon should this be helpful.
